Molecular remission is an independent predictor of clinical outcome in patients with mantle cell lymphoma after combined immunochemotherapy: a European MCL intergroup study
分子缓解是套细胞淋巴瘤患者接受联合免疫化疗后临床结局的独立预测因子:一项欧洲套细胞淋巴瘤多中心研究
期刊:Blood
影响因子:23.1
doi:10.1182/blood-2009-06-230250
Pott, Christiane; Hoster, Eva; Delfau-Larue, Marie-Helene; Beldjord, Kheira; Böttcher, Sebastian; Asnafi, Vahid; Plonquet, Anne; Siebert, Reiner; Callet-Bauchu, Evelyne; Andersen, Niels; van Dongen, Jacques J M; Klapper, Wolfram; Berger, Françoise; Ribrag, Vincent; van Hoof, Achiel L; Trneny, Marek; Walewski, Jan; Dreger, Peter; Unterhalt, Michael; Hiddemann, Wolfgang; Kneba, Michael; Kluin-Nelemans, Hanneke C; Hermine, Olivier; Macintyre, Elizabeth; Dreyling, Martin